Neuropediatrics 2004; 35(5): 307-311
DOI: 10.1055/s-2004-821253
Short Communication

Georg Thieme Verlag KG Stuttgart · New York

Large-Cell Medulloblastoma in Aicardi Syndrome. Case Report and Literature Review

L. Palmér1 , C. Nordborg2 , K. Steneryd3 , P. Åman4 , M. Kyllerman5
  • 1Department of Paediatrics, Umeå University Hospital, Umeå, Sweden
  • 2Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden
  • 3Department of Radiology, The Queen Silvia Children's Hospital, University of Göteborg, Göteborg, Sweden
  • 4Lundberg Laboratory for Cancer Research, The Sahlgrenska Academy, University of Göteborg, Göteborg, Sweden
  • 5Department of Paediatric Neurology, The Queen Silvia Children's Hospital, University of Göteborg, Göteborg, Sweden
Further Information

Publication History

Received: March 12, 2004

Accepted after Revision: July 15, 2004

Publication Date:
08 November 2004 (online)

Preview

Abstract

An eight-year-old girl with Aicardi syndrome (AIC) developed signs of increased intracranial pressure. A clinical and radiological investigation revealed a tumor in the posterior fossa, which was resected. The histopathological diagnosis was large-cell medulloblastoma. Eight months later, she died of a local recurrence, despite treatment with chemotherapy and radiotherapy according to a PNET protocol. In addition to the growth of a large-cell medulloblastoma at the location of the primary tumor and the meningeal spread of the tumor, the autopsy revealed major cortical and subcortical malformations of the brain. Various benign (e.g., plexus papillomas) and malignant tumors (angiosarcoma, embryonic carcinoma, and hepatoblastoma) have been reported in connection with Aicardi syndrome. A genetic analysis of AIC suggests that the mutation is localized on the distal part of the short arm of the X chromosome, an area that may be of importance for tumor development. This is the first report of a primary malignant brain tumor - large-cell medulloblastoma - in a patient with Aicardi syndrome.

References

Dr. Lars Palmér

Department of Paediatrics
Umeå University Hospital

901 85 Umeå

Sweden

Email: lars.palmer@vll.se